PaceMate® Company Profile
Background
PaceMate® is a healthcare technology company specializing in cardiac remote monitoring and data management solutions. Founded in 2015, the company is headquartered in Sarasota, Florida. PaceMate® is dedicated to modernizing digital healthcare by providing comprehensive, cloud-based platforms that integrate data from implantable and wearable cardiac devices with electronic health records (EHRs). This integration aims to enhance patient care, streamline clinical workflows, and improve operational efficiency.
Key Strategic Focus
PaceMate® focuses on delivering a unified platform, PaceMateLIVE™, which consolidates data from various cardiac devices and EHRs. The platform is designed to:
- Enhance Patient Care: By providing real-time, actionable insights, clinicians can make informed decisions promptly.
- Streamline Clinical Workflows: Automating data aggregation and analysis reduces manual tasks, allowing healthcare providers to focus more on patient care.
- Improve Operational Efficiency: The platform offers tools for billing automation, staff performance analytics, and device usage monitoring.
PaceMate® serves a diverse clientele, including hospitals, health systems, and independent clinics, aiming to modernize cardiac care delivery through technological innovation.
Financials and Funding
As of the latest available data, PaceMate® has raised a total of $8 million in funding. The company has secured investments from Lead Edge Capital, Ballast Point Ventures, and Dreamit HealthTech. These funds are intended to support the expansion of PaceMateLIVE™, enhance product development, and scale operations to meet the growing demand for advanced cardiac monitoring solutions.
Pipeline Development
PaceMate® has developed the PaceMateLIVE™ platform, which integrates data from implantable and wearable cardiac devices with EHRs. The platform is designed to:
- Automate Data Aggregation: Collects and consolidates data from various cardiac devices and EHRs in real-time.
- Provide Actionable Insights: Delivers real-time alerts and analytics to clinicians for prompt decision-making.
- Enhance Workflow Efficiency: Offers tools for billing automation, staff performance analytics, and device usage monitoring.
The platform is currently operational and being utilized by healthcare providers across the United States.
Technological Platform and Innovation
PaceMate®'s proprietary platform, PaceMateLIVE™, offers several innovative features:
- Comprehensive Data Integration: Integrates data from implantable and wearable cardiac devices with EHRs, providing a unified view of patient information.
- Real-Time Monitoring: Offers continuous, real-time monitoring of cardiac device data, enabling prompt clinical responses.
- Automated Workflow Management: Automates data aggregation, analysis, and reporting, reducing manual tasks and enhancing operational efficiency.
- Interoperability: Listed in Epic’s App Orchard, facilitating seamless integration with Epic's EHR system.
Leadership Team
PaceMate® is led by a team of experienced professionals:
- JR Finkelmeier, Chief Executive Officer: With over two decades of experience in healthcare and medical technology, JR joined PaceMate® in May 2024 as Chief Commercial Officer and became CEO in 2025. Prior to PaceMate®, he served as Business Leader of ECG Solutions at Philips.
- Chandler Yoquelet, President and Chief Financial Officer: Chandler oversees product, professional services, financial, risk, and technological aspects of the company. He has held senior leadership roles in med tech and professional services industries, focusing on organizational transformation and scaling.
- Gabe Rosu, Chief Technology Officer and Co-Founder: Gabe leads the technological direction of PaceMate®, ensuring the platform's innovation and scalability.
- Ryan Barone, Senior Vice President of Sales and Marketing: Ryan brings over two decades of experience in biotechnology, medical device, and healthcare technology sectors, leading sales, marketing, and business development functions at PaceMate®.
- Noemi Ray, Senior Vice President of Clinical Operations and Co-Founder: Noemi leads clinical operations, focusing on integrating clinical expertise with technological solutions to enhance patient care.
Market Insights and Competitor Analysis
The cardiac remote monitoring market is experiencing significant growth, driven by the increasing prevalence of cardiac diseases and the need for efficient patient management solutions. Healthcare providers are seeking technologies that offer real-time monitoring, data integration, and improved patient outcomes.
PaceMate® faces competition from several companies in the cardiac monitoring space:
- Murj: Offers a platform for remote monitoring of cardiac devices, focusing on data aggregation and patient management.
- CardioDiagnostics: Provides diagnostic services and remote monitoring solutions for cardiac patients.
- Cardiac RMS: Specializes in remote monitoring services for cardiac devices, aiming to improve patient care and operational efficiency.
These competitors offer similar services but differ in their technological approaches and market focus.
Strategic Collaborations and Partnerships
PaceMate® has established strategic partnerships to enhance its platform's capabilities:
- Medtronic Acquisition: In 2024, PaceMate® acquired Medtronic's PaceArt Optima cardiac workflow solution, gaining exclusive access to PaceArt device data and integrating it into PaceMateLIVE™.
- Epic Systems Integration: PaceMate® is listed in Epic’s App Orchard, facilitating seamless integration with Epic's EHR system and expanding its reach within healthcare organizations.
Operational Insights
PaceMate® differentiates itself through its comprehensive data integration, real-time monitoring capabilities, and automated workflow management. The acquisition of PaceArt and integration with Epic's EHR system enhance its interoperability and appeal to healthcare providers seeking efficient cardiac care solutions.
Strategic Opportunities and Future Directions
PaceMate® is well-positioned to capitalize on the growing demand for advanced cardiac monitoring solutions. Future opportunities include:
- Expansion of AI Capabilities: Integrating artificial intelligence to enhance data analysis and predictive analytics.
- Global Market Penetration: Extending services to international markets with increasing healthcare digitization.
- Product Diversification: Developing additional features and services to address a broader range of cardiac care needs.
Contact Information
- Website: PaceMate®
- LinkedIn: PaceMate®
- Twitter: @PaceMate
- Facebook: PaceMate
- Instagram: @PaceMate